SCHEMBL3934052

SCHEMBL3934052

COc1ccc([N+](=O)[O-])cc1C(=O)Nc1cccnc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.69
KMT2A Q03164 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.67
POLB P06746 2/20 0.66
MAPT P10636 4/20 0.63
KDM4E B2RXH2 1/20 0.63
NPC1 O15118 1/20 0.63
TSHR P16473 1/20 0.63
RAB9A P51151 1/20 0.63
CYP11B1 P15538 1/20 0.61
CYP11B2 P19099 1/20 0.61
LMNA P02545 1/20 0.59
NPSR1 Q6W5P4 2/20 0.58
MAPK1 P28482 1/20 0.58
ALPL P05186 1/20 0.57
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 2/20 0.57
HTT P42858 1/20 0.57
LCLAT1 Q6UWP7 1/20 0.55
LRRK2 Q5S007 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3933183 0.85 SMN1; SMN2 (0.71) KMT2ASMN1; SMN2POLBMAPTCYP11B1
SCHEMBL26758011 0.84 SMN1; SMN2 (0.74) KMT2ASMN1; SMN2POLBMAPTNPC1
SCHEMBL5796376 0.84 SMN1; SMN2 (0.58) GAAKMT2ASMN1; SMN2POLBMAPT
SCHEMBL3937705 0.82 SMN1; SMN2 (0.82) KMT2ASMN1; SMN2POLBMAPTNPC1
SCHEMBL3936626 0.82 SMN1; SMN2 (0.71) KMT2ASMN1; SMN2POLBMAPTNPC1
SCHEMBL4033553 0.82 SMN1; SMN2 (0.56) GAAKMT2ASMN1; SMN2POLBMAPT
SCHEMBL13163081 0.81 POLB (0.70) GAAKMT2ASMN1; SMN2POLBMAPT
SCHEMBL3936760 0.81 GAA (0.76) GAASMN1; SMN2POLBMAPTKDM4E
SCHEMBL5026608 0.80 KMT2A (0.57) GAAKMT2ASMN1; SMN2MAPTKDM4E
SCHEMBL30322736 0.80 LRRK2 (0.73) SMN1; SMN2LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed